CVC Capital Partners has acquired a 50% stake in Germany-based DFE Pharma, a manufacturer of excipients for the pharmaceutical industry, from New Zealand-listed dairy company Fonterra for NZD 633m (€363m).
Aliter Capital formed North via a buy-and-build strategy for portfolio company Boston Networks
GP invested EUR 60m for a minority stake in the environmental commodities trading platform in 2018
European growth technology investor held a final close for its debut vehicle in 2018 on EUR 400m
Alto Capital III fund secured a majority stake in the food products manufacturer in 2017